Children News and Research

RSS

Lifelong Mobility Project gets under way in Mexico

A team of global partners has tasked itself with the daunting challenge of bringing mobility to disabled children of developing nations.

23 May 2012

B cells in breast milk can produce HIV-neutralizing antibodies

Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, and showed that the B cells in breast milk can generate neutralizing antibodies that may inhibit the virus that causes AIDS.

23 May 2012

Failing combination asthma therapy may lead to SAFS in children

New research presented at the ATS 2012 International Conference in San Francisco suggests that a significant proportion of children with asthma failing Step 4 or greater therapy may have severe asthma with fungal sensitization (SAFS).

23 May 2012

Georgia researchers create map of the human brain

University of Georgia researchers have developed a map of the human brain that shows great promise as a new guide to the inner workings of the body's most complex and critical organ.

23 May 2012

Benefits of ICS treatment vary among children with differing demographic, clinical characteristics

A further analysis of a previously published National Heart, Lung, and Blood Institute (NHLBI) funded study of children with mild persistent asthma reports the relative benefits of inhaled corticosteroid (ICS) treatment varies among children with differing demographic and clinical characteristics.

23 May 2012

Folic acid fortification may reduce incidence of some childhood cancers

Researchers from the University of Minnesota and Washington University in St. Louis have found folic acid fortification of grain products in the United States may have an impact on lowering some childhood cancers.

23 May 2012

H1N1 flu vaccination during pregnancy provides unanticipated benefits to the baby

Getting a flu shot during pregnancy provides unanticipated benefits to the baby, according to the authors of a large population-based study examining the issue. Specifically, the study showed that H1N1 vaccination during the pandemic was associated with a significantly reduced risk of stillbirth, preterm birth and extremely small babies at birth.

23 May 2012

Children with craniofacial disorders face numerous medical challenges beyond appearance

Children born with cleft lip, cleft palate and other craniofacial disorders face numerous medical challenges beyond appearance.

23 May 2012

NIH Pain Consortium selects 11 health professional schools as CoEPEs

The National Institutes of Health Pain Consortium has selected 11 health professional schools as designated Centers of Excellence in Pain Education (CoEPEs).

23 May 2012

Glytec receives FDA clearance for Glucommander 2.0 Enterprise software

Glytec, LLC, headquartered in Greenville, SC, announced today that its Glucommander 2.0 Enterprise software has been cleared by the FDA for pediatric use, ages 2 - 17.

22 May 2012

Opinion pieces discuss global action on food security

The Hill's "Congress Blog" on Friday published two opinion pieces addressing global food security, the G8 summit, and the New Alliance for Food and Nutrition Security.

22 May 2012

C. difficile infection on the rise

A study presented by Mayo Clinic researchers during Digestive Disease Week 2012 provides clear evidence that the number of people contracting the hard-to-control and treat bacterial infection Clostridium difficile (C. difficile or C. diff) is increasing, and that the infection is commonly contracted outside of the hospital.

22 May 2012

Tackling 'hidden crisis' of childhood undernutrition critical

"Nearly more than 170 million children under age five suffer from undernutrition, a hidden crisis that robs them -- and their countries -- of a healthy and prosperous future," Cat Cora, chef and founder of Chefs for Humanity, writes in an opinion piece on the Feed the Future website.

22 May 2012

Inexpensive sleep disorder drug appears to be potent inhibitor of cancer cells

An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new study led by scientists at Fred Hutchinson Cancer Research Center.

22 May 2012

AAPA honors Touro University founder with PA Service to the Underserved Award

Three years ago, Vicki Chan-Padgett, PA-C, of Las Vegas, Nev., stumbled upon a troubling reality within the city's healthcare sector. Thousands of women and their children who were homeless or survivors of domestic abuse could not afford much-needed healthcare. Inspired to take action, Chan-Padgett opened a first-of-its-kind clinic to provide free, high-quality healthcare to Las Vegas women and children who need it most.

22 May 2012

Noninvasive test can reduce feeding-related complications among premature infants

Tufts Medical Center researchers have shown that presence of a gene strongly linked to appetite regulation is highly predictive of a premature infant's readiness to feed orally. An analysis of just a drop of an infant's saliva could be the key to preventing many feeding problems and the expensive medical complications that can occur when infants are fed by mouth too early.

22 May 2012

FSU announces availability of Pacifier Activated Lullaby device

Many premature babies enter the world with a mountain of challenges in front of them. Even after they overcome any life-threatening issues, they face ongoing, and typically unpleasant, medical procedures, long hospital stays and increased chances of chronic health issues throughout their lives.

22 May 2012

New knowledge related to host-parasite interaction in severe malaria

Researchers from Seattle Biomedical Research Institute, the University of Copenhagen and the University of Edinburgh have uncovered new knowledge related to host-parasite interaction in severe malaria, concerning how malaria parasites are able to bind to cells in the brain and cause cerebral malaria - the most lethal form of the disease.

22 May 2012

New strategy can reactivate genes that cause cancer tumors to shrink and die

A team of scientists has developed a promising new strategy for "reactivating" genes that cause cancer tumors to shrink and die. The researchers hope that their discovery will aid in the development of an innovative anti-cancer drug that effectively targets unhealthy, cancerous tissue without damaging healthy, non-cancerous tissue and vital organs.

22 May 2012

$Children with pelvic and thigh fractures rarely develop dangerous blood clots$

Children with pelvic and thigh fractures rarely develop dangerous blood clots

Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center.

21 May 2012